Isolates were cultured under conditions designed to simulate in vivo stresses. Substantial variation 20 was seen across morphological and clinical data. Giant cells were more common in C. tetragattii, 21 while micro cells and shed capsule occurred in C. neoformans only. Phenotypic variables fell into 22 two groups associated with differing symptoms. The production of "large" phenotypes (greater cell 23 and capsule size and giant cells) was associated with higher CD4 count and was negatively correlated 24 with intracranial pressure indicators, suggesting these are induced in early-stage infection. "Small" 25 phenotypes (micro cells and shed capsule) were associated with lower CD4 counts, negatively 26 correlated with meningeal inflammation indicators and positively correlated with intracranial 27 pressure indicators, suggesting they are produced later during infection and may contribute to 28 immune suppression and promote proliferation and dissemination. These trends persisted at the 29 species level, indicating that they were not driven by association with particular Cryptococcus 30 species. Isolates possessing giant cells, micro cells, and shed capsule were rare, but strikingly were 31 associated with patient death (p=0.0165). Our data indicate that pleomorphism is an important driver 32 in Cryptococcus infection. 33
Importance 34
Cryptococcosis results in hundreds of thousands of deaths annually, predominantly in sub-Saharan 35
Africa. Cryptococcus is an encapsulated yeast, and during infection cells have the capacity for 36 substantial morphological changes, including capsule enlargement and shedding, and variations in 37 cell shape and size. In this study we examined 70 Cryptococcus isolates causing meningitis in 38 HIV/AIDS patients in Botswana in order to look for associations between phenotypic variation and 39 clinical symptoms. Four variant phenotypes were seen across strains: giant cells ≥ 15 µm, micro cells 40 ≤ 1 µm, shed extracellular capsule, and irregularly shaped cells. We found "large" and "small" 41 phenotypes were associated with differing disease symptoms, indicating that their production may be 42 important during the disease process. Overall, our study indicates that Cryptococcus strains that can 43 Substantial differences in genetic diversity were seen among genotypes. The C. tetragattii/VGIV 88 population had a largely clonal structure with 12 out of 16 isolates belonging to ST 221 and limited 89 divergence of the remaining isolates, while all C. neoformans genotypes showed much more 90 diversity, with VNBI having the highest level. Evidence of recombination, shown as loops in the 91 networks, was seen in the VNBI and VNBII populations. 92
Induced capsule and cell size differ between species and genotypes 93
Capsule thickness and yeast cell diameter were measured after growth in DMEM broth with 5% CO 2 94 at 37 °C for 5 days, and data were compared across genotypes for mean and variation (Table 1 ; Fig.  95 2A-C). On average, C. tetragattii isolates had significantly greater capsule thickness (p=0.0025) and 96 yeast cell diameter (p<0.0001) than C. neoformans isolates. Within C. neoformans genotypes, VNBI 97 isolates had significantly greater capsule thickness than VNI isolates (p=0.0043) and significantly 98 greater yeast cell diameter than VNI (p=0.0032) and VNBII (p=0.0178) isolates. F test analysis was 99 used to compare the variance of the data (Table 1) . Despite their limited genetic diversity, C. 100 tetragattii isolates had significantly more variation in capsule thickness than C. neoformans isolates 101 (p=0.0245). There were no significant differences in variation in capsule thickness among C. 102 neoformans genotypes. Yeast cell diameter measurements did not vary significantly different 103 between any groups. 104
Giant cells are more frequent in C. tetragattii while micro cells and extracellular capsule are 105 present only in C. neoformans 106
Following growth under inducing conditions, the three variant phenotypes seen at differing 107 frequencies across isolates were giant cells (yeast cell diameter ≥ 15 µm) ( Fig. 3A) , micro cells (yeast 108 cell diameter ≤ 1 µm) ( Fig. 3B ) and shed capsule (Fig. 3C ). Elongated and irregularly shaped cells 109 were seen in a number of strains across all genotypes (except VNII where n=2) (Supplementary 110 Figure S1D , Table 1 ) but these comprised a small subset (<5%) of the total population of cells. Cells 111 larger than 15 µm have previously been classed as "titan cells", however as in vivo titan cells possess 112 additional defining characteristics that were not measured in this study including altered capsular 113 structure, increased DNA content and increased vacuolar formation (27), they will be here referred to 114 as giant cells. The number of clinical isolates exhibiting these morphological variants for each 115 genotype is summarised in Table 1 . Giant cells were significantly associated with greater capsule 116 thickness (p<0.0001) and yeast cell diameter (p<0.0001) indicating that isolates with larger cells are 117 more likely to produce giant cells, and Fig. 2B shows that cell size is generally spread along a 118 continuum. Micro cells and shed capsule, however, were not significantly associated with capsule 119 thickness or yeast cell diameter in C. neoformans indicating that cell size is not related to their 120 production and that micro cells are a distinct cell type rather than the endpoint of a continuum of 121 increasingly smaller cells. 122
The production of giant cells was significantly associated with C. tetragattii (50% of isolates; 123 p=0.0070) compared to C. neoformans (15% of isolates) while micro cells and shed capsule were 124 only seen in C. neoformans (58 and 81% of isolates, respectively) and were significantly associated 125 7 Correlations were assessed between clinical, phenotypic, and genotypic variables across the isolate 134 collection. Correlation plots were generated showing the direction, strength, and statistical 135 significance of correlations between clinical variables overall ( Fig. 4A ), between phenotypic 136 variables overall (Fig. 4B ), and between clinical and phenotypic variables overall and, for certain 137 clinical variables, for C. neoformans and C. tetragattii species individually ( Fig. 4C ). All other 138 analyses and individual p-values are recorded in Supplementary Table 2 . Principal component 139 analysis (PCA) was used to investigate the variance and dimensionality of the dataset. PCA biplots 140 were generated using the first two components for clinical data accounting for 25.4% of variation 141 ( Fig. 4D ) and for phenotypic data accounting for 61.9% of variation ( Fig. 4E ). 142
Most of the significant associations found between clinical symptoms were as expected, with similar 143 variables being positively correlated including fever and temperature (p<0.0001), cough and chest 144 pain (p=0.0013), altered mental status and behavioural changes (p<0.0001), and nausea and vomiting 145 (p<0.0001). Similarly, cognitive symptoms such as confusion, behavioural changes, and altered 146 mental status; respiratory symptoms such as cough, shortness of breath, chest pain, and respiratory 147 rate; and intracranial symptoms such as visual changes, blurred vision, neck pain, and photophobia 148 grouped closely together in the PCA biplot of clinical variables ( Fig 4D) . Given the complexity of 149 clinical data that relies on self-reporting by patients that may be quite ill and subsequent 150 interpretation by clinicians, this serves as a as a useful internal control for data quality. Patient death 151 was significantly positively correlated with respiratory rate (p=0.0101), cerebellar signs (p=0.0478) 152 and CSF CFU (p=0.0048). 153
The capacity for production of "large" and "small" phenotypes correlates with certain clinical 154 symptoms indicative of early and late stage infection, while the capacity for variation is 155 associated with patient death 156
In the PCA biplot of phenotypic variables ( Fig. 4E) , properties based on cell and capsule size 157 grouped closely together along with giant cells, while micro cells and shed capsule grouped closely 158 with each other and away from the other properties. These groups were a strong driver of variation in 159 the biplot, indicating genotype-specific differences, while the production of irregular cells did not. 160
When correlated with clinical data, the phenotypic variables within these groups showed similar 161 directions and strengths of association, with "large" phenotypes including greater capsule thickness, 162 greater yeast cell diameter, and giant cells generally grouping and often opposing the "small" 163 phenotypes of micro cells and shed capsule ( Fig. 4C) . 164
CD4 T-cell count is a reliable predictor of host immune status, with counts <500 indicating immune 165 suppression, and <200 in HIV-infected individuals indicating AIDS. In the current study, CD4 counts 166 ranged from 2-389 ( Supplementary Table 1 ). Overall, CD4 count was positively correlated with cell 167 size across the entire dataset (p=0.0250) and negatively correlated with the production of shed 168 capsule (p=0.0158). Nausea and vomiting are frequent symptoms of increased intracranial pressure 169 during cryptococcosis and these were negatively correlated with "large" cell phenotypes: nausea was 170 negatively correlated with yeast cell diameter (p=0.0135) and giant cells (p=0.0357), and vomiting 171 was negatively correlated with all "large" phenotypes including total diameter (p=0.0007), yeast cell 172 diameter (p=0.0010), capsule thickness (p=0.0014), volume ratio (p=0.0269) and giant cells 173 (p=0.0041). Vomiting was also positively correlated with the "small" phenotypes including micro 174 cells (p=0.0077) and shed capsule (p=0.0153). Shed capsule was also negatively correlated with 175 visual changes (p=0.0358) and photophobia (p=0.0032), symptoms typically attributed to meningeal 176 irritation. A similar pattern was seen with fever and neck stiffness, which are associated with an 177 aggressive inflammatory response. Patient temperature was positively correlated with total diameter 178 (p=0.0412), capsule thickness (p=0.0104) and volume ratio (p=0.0016) in the C. neoformans isolates, 179 while neck stiffness correlated negatively with micro cells across the entire collection (p=0.0041). 180 Finally, patient death was significantly positively correlated with the production of all three major 181 morphological variants (p=0.0165); four patients had isolates that produced giant cells, micro cells 182 and shed capsule, and all four patients died during the period when clinical data were scored. The 183 production of all three major morphological variants was also positively correlated with the patient 184 having tuberculosis (p=0.0133), and negatively correlated with systolic blood pressure (p=0.0474). In 185 contrast, irregular cells were negatively correlated with death (p=0.0241). These were also more 186 likely to be produced by isolates obtained from patients who had undergone antifungal therapy with 187 either fluconazole or amphotericin B prior to admission (p=0.0438). All of the above associations 188 were tested for each species alone as well as across the entire dataset, and the trends remained largely 189 the same, although some statistical power was lost due to smaller sample sizes, indicating that these 190 results were not being driven by an association with one of the species. 191
Some correlations show species-specificity 192
Several species-specific correlations were found, indicating that aspects of pathogenesis and host 193 response are distinct between C. neoformans and C. tetragattii isolates. In the PCA biplot of 194 phenotypic variables, the C. tetragattii isolates grouped mostly separately from C. neoformans 195 isolates due to their larger cell and capsule sizes, higher incidence of giant cells, and lack of micro 196 cells and shed capsule ( Fig. 4E ). C. neoformans isolates were significantly associated with lower 197 CD4 count (p=0.0103), higher LP opening pressure (p=0.0208) and vomiting (p=0.0013) compared 198 to C. tetragattii. Isolates from the C. neoformans genotype VNBI were significantly associated with 199 lower CD4 count (p=0.0063) and lower diastolic blood pressure (p=0.0235) compared to all other 200 isolates ( Supplementary Table 2 ). In the C. neoformans population, shortness of breath was 201 positively correlated with total diameter (p=0.0430), capsule thickness (p=0.0366) and volume ratio 202 (p=0.0367). In C. tetragattii isolates, yeast cell diameter was positively correlated with dizziness 203 (p=0.0292) and negatively correlated with respiratory rate (p=0.0335). 204
Discussion 205
Our study aimed to correlate phenotypic variation in cryptococcal isolates with pathogenesis and 206 clinical manifestation of disease using in vitro stresses designed to simulate those encountered during 207 human infection. The observed phenotypes were a stable attribute of the isolates, although we cannot 208 be certain that these phenotypes would occur in infected patients in the same way. Furthermore, the 209 clinical dataset used in this study contains missing values, and certain parameters rely on self-210 reporting, which may not be very robust. Despite this, we saw some strong correlations and trends, 211 and while this does not necessarily imply causation, the strength and pattern of the associations 212 indicates that phenotypic plasticity and morphological presentation do play a role in cryptococcal 213
disease. 214

Phenotypic plasticity is high and not related to genetic diversity 215
Almost a quarter of the clinical isolates in this study were identified as C. tetragattii, a species which 216 is uncommon globally but has been found to cause a relatively high incidence of disease in 217 HIV/AIDS patients in sub-Saharan Africa, having been identified in Botswana, Malawi, South 218 Africa, and Zimbabwe (10, 28-30). Relatively little is known about this species, however our 219 previous study of the C. gattii complex found that C. tetragattii is similar to other species in the 220 complex in terms of capsule production and cell size, but along with C. bacillisporus is more 221 temperature sensitive than virulent genotypes C. gattii and C. deuterogattii, and commonly produces 222 irregular cells. This suggests that C. tetragattii is a "weaker" pathogen and may be infecting 223 immunocompromised hosts due to high environmental presence in Botswana and other sub-Saharan 224
African countries. Environmental studies of the area are needed to determine where its niche lies. 225 MLST analysis revealed a limited amount of genetic diversity among C. tetragattii isolates, which 226 contrasted with high genetic diversity and evidence of recombination in the C. neoformans genotypes 227 (Table 1; Fig. 1 ), something that has been seen in other studies of southern African C. neoformans 228 populations (29, 31-33). Significant phenotypic differences occurred among, between and within the 229 C. neoformans genotypes and within C. tetragattii and, despite their clonal nature, C. tetragattii 230 isolates had significantly more variation in capsule thickness (p=0.0245), suggesting that some 231 phenotypic differences may be a result of epigenetic mechanisms. Rhodes et al. (2017) found the 232 most rapidly evolving genes between lineages of C. neoformans to be transcription factors and 233 transferases, suggesting that transcriptional reprogramming and remodelling may be responsible for 234 generating phenotypic diversity, rather than genomic changes (34). Phenotypic plasticity allows rapid 235 adaptation inside the host and is common in many fungal species, such as Candida albicans, which 236 can exhibit various morphological types including yeast and filamentous forms, and white and 237 opaque forms which influence mating, virulence, and interactions with immune cells in vitro (35). 238
Cryptococcus, like Candida, appears to show a level of pleomorphism with different phenotypes 239 appearing in response to stress. 240
Clinical markers of early and late infection suggest cell phenotypes change during the course of 241 infection and may play a role in immune response 242
A model of the relationship between the various phenotypic variants, cryptococcal species, and 243 clinical variables based on the significant associations and trends found in this study is presented in 244 with "large" phenotypes suggesting that larger cells, more capsule, and giant cells are produced 246 during earlier stages of infection, and overall negatively correlated with "small" phenotypes 247 suggesting that micro cells and shed capsule may be a later response during infection as immune 248 function declines ( Fig. 4C; Fig. 5 ). Nausea and vomiting are symptoms that are typically associated 249 with increased intracranial pressure as this results in stimulation of the vomiting center of the brain. 250
These were overall negatively correlated with "large" phenotypes again suggesting that larger cells 251 may be an earlier response, and overall positively correlated with "small" phenotypes. The latter 252 could be expected as shed capsule in particular has long been implicated in increasing intracranial 253 pressure due to the accumulation of capsular polysaccharide blocking passage of the CSF across 254 arachnoid villi (36). In all, this suggests a transition from "large" to "small" cell phenotypes as 255 infection progresses and intracranial pressure rises. 256
The "small" phenotypes were also overall negatively correlated with visual changes (significantly 257 with shed capsule, p=0.0358) and photophobia (significantly with shed capsule, p=0.0032), 258 symptoms associated with inflammation of the meninges (43). It has been observed that cryptococcal 259 meningitis in HIV patients is characterised by a lack of an active host inflammatory response (36) so 260 it is possible that micro cells and extracellular capsule accumulating in the CSF and causing raised 261 intracranial pressure might also be dampening the host inflammatory response. The major 262 cryptococcal capsular polysaccharide (GXM), has been documented to have numerous 263 immunosuppressive properties including modulation of cytokine secretion, induction of macrophage 264 apoptosis, and suppression of leukocyte migration (37-40). Studies in mice have found GXM to 265 markedly dampen the hyperinflammatory response via inhibition of proinflammatory cytokine 266 secretion (41), and the administration of purified GXM reduced the number of immune cells 267 infiltrating the brain (42) 268
Capsule size in cryptococcal cells was found to differ significantly between genotypes, species, and 269 individual isolates (Table 1 ; Fig. 2A Pool et al. (2013) showed that hypercapsular C. neoformans isolates 275 possessed the least neurovirulence in a mouse model, while isolates producing less capsule were 276 more virulent and resulted in a higher fungal load in the brain (44). As such, it is unclear whether a 277 large capsular phenotype enhances the overall virulence of Cryptococcus. Our current study found 278 that capsule size strongly correlates with yeast cell size, and it is possible that capsule alone has less 279 importance than the overall size of the cell. found giant cells to be significantly associated with larger average yeast cell diameters (p<0.0001) 296 and greater capsule thickness (p<0.0001) in both C. neoformans and C. tetragattii (Fig. 3A) which 297 supports the hypothesis of a gradual shift towards a larger phenotype. Although the majority of 298 literature on giant cells relates to C. neoformans, we found that the presence of giant cells was 299 significantly associated with the C. tetragattii complex. 300
Cryptococcus micro cells are an intriguing and understudied class of cell that has to date received 301 little attention. These cells are commonly seen in infection and have been speculated to assist in the 302 infection process, with their small size allowing them cross biological barriers and to disseminate 303 easily to the brain (14, 44). The presence of micro cells was strongly (p<0.0001), but not always, 304 associated with shed capsule (Table 1 ; Supplementary Table 2 ) suggesting that they are induced by 305 the same or similar processes. Staining with DAPI and calcofluor white, confirmed that micro cells 306 are real cells with nuclear material and cell walls, and are distinct from shed capsule ( Fig. 3D-E) . 307 Furthermore, unlike giant cells, micro cells appear to be a distinct cell class as there was no 308 correlation with cell size, indicating that there is no continuum of increasingly smaller cells. Their 309 presence appears to be exclusive to C. neoformans (and seen across genotypes); the current analysis 310 and our previous study investigating 70 C. gattii complex strains including C. gattii, C. deuterogattii, 311 C. bacillisporus, and C. tetragattii clinical, environmental, and veterinary strains and found no 312 evidence of micro cells in any strain (26). 313
Pleomorphism may have a role in the virulence of Cryptococcus 314
The production of "large" and "small" phenotypes was largely mutually exclusive; most isolates 315 possessed either giant cells or micro cells/shed capsule but rarely both. It is therefore intriguing that 316 the four isolates that produced all three major morphological size variants (giant cells, micro cells, 317 and shed capsule) resulted in patient death (p=0.0165) ( Fig. 4C ). While this must be viewed with the 318 limitation that there were very few isolates within this category, it may indicate that the capacity for 319 variation plays a role in virulence. Three out of four of these isolates belonged to VNBI, which 320 appeared to be the most virulent genotype with the highest percentage of patient deaths, and also with 321 the largest average capsule sizes within C. neoformans. As "large" and "small" variants appear 322 associated with quite different disease symptoms, this could enable greater capacity for infection, 323 immune evasion, and pathogenesis. An alternative hypothesis is that in the severely weakened 324 immune state of late HIV/AIDS patients, different cryptococcal cell types can flourish; however 325 many isolates caused patient death but did not demonstrate this diversity of cell types. Further work 326 into the factors that induce each of these unique cell types and their role in virulence and disease 327 progression is required to substantiate this preliminary finding. 328
Conversely, the presence of "irregular cells" with irregularly shaped and elongated cell morphologies 329 was significantly negatively correlated with death (p=0.0241) suggesting that these are defective 330 cells. Irregular cells were not associated with any particular species or genotype and had no 331 significant correlations with any other phenotypic variable, but they were significantly more likely to 332 occur in isolates isolated from patients that had undergone antifungal therapy prior to admission 333 (p=0.0438). This suggests that irregular cells may be produced by isolates with reduced drug 334 susceptibility but with a cost of lower resistance to host-imposed stress, making them less able to 335 mount aggressive disease. In vitro, we have found the production of these cells may be triggered by 336 the stress of nutrient limitation (26). The extent of the elongation of these cells varied from isolate to 337 isolate, but in some cases they appeared to approach the morphology of pseudohyphal forms. 338
Pseudohyphal forms have been reported in Cryptococcus but are thought to be rare during 339 cryptococcosis and are also associated with reduced virulence (27, 50) . 340
This study demonstrates the complex relationship between phenotypic variation and adaptation to the 341 host environment in Cryptococcus, with pleomorphic characters potentially contributing to overall 342 virulence. As different properties may be beneficial at different stages and sites of infection, isolates 343 that are able to produce diverse cells in response to changing situations may be more able to sustain 344 infection and resist the host response. 345
Materials & Methods 346
Cryptococcus isolates 347
A collection of 70 Cryptococcus isolates were provided from two major public hospitals in 
Culture conditions 361
Cryptococcus isolates were cultured from -80 °C glycerol stocks, streaked for single colonies on 362 Sabouraud Dextrose Agar (SDA; 10 g peptone, 40 g glucose, 15 g agar, 1 L dH 2 O) and incubated at 363 30 °C for 48 hours. To standardise growth phase, each isolate was grown overnight from a single 364 colony in 10 ml of Sabouraud Dextrose Broth (SDB; 10 g peptone, 20 g glucose, 1 L dH 2 O) in a 100 365 ml Schott bottle at 37 °C with 180 rpm shaking until the culture reached exponential growth phase. 366
Capsule induction 367
Capsule induction was optimised using various media designed to mimic stresses encountered during 368 mammalian infection that are frequently used for C. neoformans, and media developed during a 369 previous study in the C. gattii complex (25). This included Dulbecco's Modified Eagle Medium 370 (DMEM; Life Technologies), and Sabouraud medium in both plate (SDA) and broth (SDB) form 371 diluted 10-fold (CIM-10), or 20-fold (CIM-20) in 50 mM MOPS (Sigma Aldrich) (13, 26). For 372 culture on agar plates, a single loopful of cells was taken from the overnight culture and streaked for 373 single colonies onto each medium. For broth cultures, cells were collected by centrifugation, washed 374 once with Phosphate-Buffered Saline (PBS; Oxoid), and counted with a haemocytometer before 10 5 375 cells were inoculated into 5 ml of media in a 6-well tissue culture plate (BD Falconer). All cultures 376 were incubated with 5% CO 2 at 37 °C for 5 days. As a control, isolates were streaked for single 377 colonies on SDA and incubated at 30 °C for 5 days. DMEM broth was the most successful induction 378 media (Supplementary Figure S1) and was used for all subsequent analyses. 379
Staining and microscopy 380
To visualise capsule, single colonies from plates or 1 ml of culture from broths were suspended or 381 resuspended in 150 μl of PBS and counterstained with 20 μl of India Ink. A 15 µl aliquot of this 382 mixture was placed on a glass slide and dried for 10 min under a coverslip. Slides were then 383 photographed using an IS10000 Inverted Microscope (Luminoptic) under the 40x objective using 384 ISCapture Imaging software (Tucsen Photonics). For each isolate, a minimum of 20 random fields of 385 view were photographed using stage coordinates determined by a random number generator. 386
Additional stains used to visualize nucleus and cell wall morphology respectively were: (i) DAPI 387 (Sigma Aldrich) at 1:5000 incubated for 30 minutes at room temperature, (ii) Calcofluor White 388 (Sigma Aldrich) at 1 g/l with one drop of 10% potassium hydroxide incubated for 2 minutes at room 389 temperature. 390
Measurement of cell and capsule size 391
Total diameter (including capsule) ( ) and yeast cell diameter ( ) were measured for 100 cells per 392 isolate using ImageJ software (National Institutes of Health). From these measurements, capsule 393 thickness ( ) was calculated as 1 2 ( − ). Total volume ( ) and yeast cell volume ( ) were 394 calculated using the formula for the volume of a sphere ( 4 3 3 ). Cells with greater than 15 μm or 395 less than 1 μm were identified as giant cells or micro cells, respectively, and were noted along with 396 any morphologically irregular cells. These variants were excluded from all assessments of mean cell 397 size for isolate populations. 398
MLST analysis 399
Genetic variation was studied using the International Society of Human and Animal Mycology 400 (ISHAM) consensus MLST scheme for the C. neoformans/C. gattii species complex, which uses 401 seven unlinked genetic loci: the housekeeping genes CAP59, GPD1, LAC1, PLB1, SOD1, and URA5, 402 and the non-coding intergenic spacer region IGS1 (51). Sequences were obtained from SNPs 403 identified from whole genome sequences, where available (52). Remaining loci were amplified 404 independently using ISHAM recommended primers and amplification conditions, and PCR products 405 were commercially purified and sequenced by Macrogen Inc. (Seoul, Korea). Sequences were edited 406 using Geneious R6 (Biomatters Ltd.). An allele type (AT) was then assigned for each of the seven 407 loci per isolate and the resulting allelic profile used to assign a sequence type (ST) according to the 408 ISHAM consensus MLST database (http://mlst.mycologylab.org). A minimum spanning network of 409 the concatenated sequences was generated using the TCS 1.21 software package 410 (http://darwin.uvigo.es/software/tcs.html) to visualise the relatedness of isolates (53). 411
Statistical analysis 412
Significant differences between species or genotypes for phenotypic or clinical data were determined 413 using two-tailed unpaired t-tests with Welch's correction. Differences in variance between species 414 and genotypes were assessed by F test analysis. Associations between continuous phenotypic and 415 clinical variables used Spearman rank-order correlations, those between continuous and binary 416 variables used Mann-Whitney U tests, and those between binary variables used chi-square tests, or 417
Fisher's exact tests if any expected value was <5. Correlations were tested across all isolates, across 418 C. neoformans isolates only, and across C. tetragattii isolates only, with all p values listed in 419 Supplementary Minimum spanning network analysis of the clinical isolates based on the concatenated sequences of 601 seven MLST loci. Each unique sequence type is represented by a circle, with size proportional to the 602 number of isolates belonging to that sequence type. Isolate names in black type correspond to 603 patients who were alive at the time of the analysis, while isolate names in white type on darker 604 backgrounds correspond to patients who died. C. neoformans VNI n = 17, VNII n = 2, VNBI n = 25, 605 VNBII n = 9, C. gattii VGI n = 1, C. tetragatiii VGIV n = 16. MLST alleles for each strain can be 606 found in Supplementary Table S1 . 607 Supplementary Table S1 : Genetic, phenotypic, and clinical data for all isolates used in this study. 654 Supplementary Table S2 : Statistical significance for all associations tested in this study. 655 
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